Related by context. All words. (Click for frequent words.) 73 PLX STROKE targeting 73 opioid naive 72 approved incretin mimetic 71 infliximab monotherapy 70 relapsed MM 70 vaccinated PNH patients 70 Budesonide foam crofelemer 69 CYT# potent vascular disrupting 69 phase IIb study 69 receiving XGEVA 69 refractory NSCLC 69 Dementia Related Psychosis 68 INSPIRE Trial Phase III 68 solid tumors ZYBRESTAT 68 deCODE AF TM 68 humanized therapeutic 68 CIMZIA TM certolizumab pegol 68 ® lenalidomide 68 myocardial infarction ventricular fibrillation 67 plus prednisone prednisolone 67 headache nasopharyngitis 67 reduce serum phosphate 67 LymphoStat B belimumab 67 decompensated liver disease 67 doxepin HCl 67 albiglutide 67 MAGE A3 ASCI 67 retinal vein occlusion induced 67 recombinant PSMA vaccine 67 zoledronic acid Reclast 67 sulfonylurea glimepiride 67 HCV NS5B polymerase 67 pharmacogenomic translational research 67 ACTEMRA TM 67 stage IIIb IV 67 IMPDH inhibitor 67 stage antibody MT# 67 prednisone prednisolone plus 67 dyslipidemia hypertension diabetes 66 BR.# 66 bone marrow reticulin deposition 66 nilotinib Tasigna ® 66 intracranial atherosclerosis 66 IMiDs 66 sulfonylurea metformin 66 EOquin TM phase 66 anthracycline taxane 66 somatostatin analog 66 Crofelemer budesonide foam 66 azilsartan medoxomil 66 metastatic GIST 66 myelodysplastic myeloproliferative diseases 66 Bayer HealthCare Onyx Pharmaceuticals 66 midstage clinical 66 mitoxantrone plus 66 CEL SCI Phase III 66 delivers fluocinolone acetonide FA 66 Empatic ™ 66 galiximab 66 markets Testim ® 66 CHAMPION PCI 66 Selzentry Celsentri 66 serum phosphorous 66 PEGINTRON TM 66 novel VDA molecule 66 relapsed refractory multiple myeloma 66 targeting miR 66 budesonide foam 66 psoriasis inflammatory bowel 66 AGILECT R 65 multicenter Phase III 65 compound INCB# 65 regorafenib 65 Mg Uk 65 REVIVE Diabetes 65 treat chronic sinusitis 65 refractory chronic lymphocytic 65 overt nephropathy 65 COU AA 65 metastatic colorectal carcinoma 65 dasatinib Sprycel ® 65 kidney urologic 65 lintuzumab SGN 65 GERD migraine headaches 65 humanized interleukin 6 65 maximally tolerated lipid lowering 65 Folfox 65 lenalidomide Revlimid R 65 recurrent glioblastoma multiforme 65 hyperphenylalaninemia HPA due 65 FUSILEV enhances 65 Ribavirin causes 65 irregular quivering 65 oxypurinol 65 TRIOLEX HE# APOPTONE HE# 65 visilizumab 65 sorafenib tablets 65 non valvular atrial 65 evaluating T DM1 65 recurrent metastatic ovarian cancer 65 ADVANCE ILLUMINATE 65 rheumatoid arthritis psoriatic arthritis 65 receiving VELCADE 65 FOLFOX6 chemotherapy regimen 65 opioid naïve 65 neuropathic pain spasticity 65 primary hypercholesterolemia 65 Amgen Neulasta ® 65 R sorafenib tablets 65 including eniluracil ADH 65 Infusion Reactions Severe 65 Telik logo TELINTRA 65 non cirrhotic portal 65 treating psychiatric disorders 65 candidate XP# 65 Mg Usa 65 CIMZIA r certolizumab pegol 65 noninvasive outpatient 65 included exfoliative dermatitis 64 gastrointestinal stromal 64 Zemplar Capsules 64 gadobutrol 64 RSD# oral 64 diarrhea vomiting nausea 64 orally inhaled migraine 64 5 lipoxygenase inhibitor 64 basal bolus therapy 64 naïve HCV 64 de novo kidney transplant 64 EEG abnormalities 64 manufactures minimally invasive 64 vascular occlusive diseases 64 echinacea tablets 64 resectable pancreatic cancer 64 antiarrhythmic drug 64 commercialize CorMedix drug 64 AAG geldanamycin analog 64 Bystolic nebivolol 64 metastatic colorectal 64 brand ciclesonide HFA 64 R Saizen R 64 dasatinib Sprycel 64 evaluating mipomersen 64 fusion enhancers 64 albiglutide currently 64 dose escalation phase 64 nasopharyngitis headache 64 blinded randomized placebo controlled 64 SILENOR TM doxepin HCl 64 Hypertensive adverse reactions 64 deep venous thromboses 64 weekly subcutaneous injections 64 severe hepatic dysfunction 64 neutropenic sepsis 64 Peginterferon alfa 2b 64 HIV treatments Reyataz 64 demonstrated antitumor activity 64 Alimentary Tract 64 opioid induced bowel dysfunction 64 evaluating tivozanib 64 relapsing remitting MS RRMS 64 class mGluR5 inhibitor 64 thrombin inhibiting aptamer 64 convulsive disorders 64 acyclovir Lauriad R 64 Amigal TM 64 R lenalidomide 64 hypertrichosis occurred 64 trauma malignant tumors 64 baminercept 64 EGFR mutation positive 64 Hormone Refractory Prostate Cancer 64 Albuferon albinterferon alfa 2b 64 OAB overactive bladder 64 pharmacologically active isomer 64 biologic DMARD 64 phase III isavuconazole 64 toenail onychomycosis 64 sequential dose escalation 64 Testosterone MDTS R 64 DepoCyt ® Abelcet ® 64 treatment naïve genotype 64 triggers apoptosis programmed 64 INVEGA ® 64 GRNOPC1 contains 64 non constipating irritable 64 Stage IIIb IV 64 IMiDs ® 64 catheter occlusion 64 undergoing elective percutaneous 63 aplindore 63 dexamethasone Decadron 63 development peramivir neuraminidase 63 vapreotide acetate 63 combines bupropion 63 PMX # heptagonist 63 essential thrombocythemia ET 63 stable angina pectoris 63 containing LABAs 63 sorafenib Nexavar ® 63 C1 INH deficiency 63 Tramiprosate ALZHEMED TM 63 developing KL4 surfactant 63 dimebon latrepirdine 63 oral rivaroxaban 63 interferon gamma 1b 63 Luramist TM 63 dirucotide MBP# 63 trastuzumab Herceptin R 63 cladribine Cladribine Tablets 63 intravesical infusion therapy 63 #mg ATC 63 FluCAM arm 63 evaluating picoplatin 63 deCODE ProstateCancer TM 63 rash pruritus nausea 63 Ovitrelle R Serostim 63 cancer indications bafetinib 63 8mg/kg 63 Cariprazine 63 TTF Therapy 63 beta blockers ACE inhibitors 63 cyclophosphamide chemotherapy 63 avanafil PDE5 inhibitor 63 system REG1 consists 63 induced mucositis 63 Amgen Neulasta R 63 metastatic renal 63 VEGFR2 inhibitor 63 maximally tolerated dose 63 M# rationally 63 RhuDex R 63 certolizumab 63 IBS C 63 non splenectomized 63 doxorubicin cyclophosphamide 63 oropharyngeal candidiasis OPC 63 progressive metastatic prostate 63 RANK Ligand inhibitor 63 PEGINTRON REBETOL combination 63 systemic ALCL 63 vinca alkaloid 63 alpha1 antitrypsin deficiency 63 inhalations twice 63 placebo controlled dose escalation 63 Teriflunomide 63 aflibercept VEGF Trap 63 either acutely decompensated 63 pyrexia mucositis sepsis febrile 63 cisplatin gemcitabine 63 elderly myelodysplastic syndromes 63 Acneform rash occurred 63 achieved ACR# 63 antidepressants fluoxetine 63 PORxin TM platforms 63 Testosterone MDTS ® 63 REVIVE TA 63 Naive Patients 63 Launches Generic Version 63 ABSORB trial 63 HIV coinfected 63 metastatic pancreatic 63 sapacitabine CYC# 63 humanised monoclonal antibody 63 hypokalemia hypomagnesemia 63 unresectable HCC 63 nephropathic cystinosis cystinosis 63 Phase III multicenter 63 oral vancomycin 63 del 5q MDS 63 onset atrial fibrillation 63 Temodar ® 63 known sulfonamide allergy 63 acetonide FA 63 oral nucleoside analogue 63 erlotinib Tarceva ® 63 antiretroviral naïve 63 tumors GIST 63 receiving INTRON 63 RhuDex TM 63 hypoxia activated prodrug 63 PEGylated docetaxel 63 Inhaled nitric oxide 63 subcutaneous enoxaparin 63 clinical trials Archexin 63 forodesine 63 riociguat 63 Contrave# 63 Xeloda ® 63 Provectus Pharmaceuticals specializes 63 morphometric vertebral fractures 63 esthesioneuroblastoma rare form 63 CTAP# 63 randomized #:#:# 63 atherosclerosis rheumatoid arthritis 63 variant angina 63 taxane chemotherapy administered 63 Completes Patient Enrollment 63 MKC# 63 castration resistant hormone refractory 63 chronic myeloid 63 diabetes sciatica 63 metastatic renal cell 63 recurrent metastatic 63 registrational Phase 63 ENL recurrence 63 non resectable metastatic 63 By JENNIFER LEARN 63 oral talactoferrin 63 HGS ETR1 mapatumumab 63 Vidaza ® 63 Phase Ib IIa 63 generation radiolabeled antibody 63 CTAP# Capsules 62 nasal corticosteroids 62 ALN VSP Phase 62 metformin sulfonylurea 62 TO AVOID PREGNANCY WHILE 62 plus dacarbazine 62 inflammatory PDE 62 NYHA Class II 62 clinically evaluable 62 placebo dexamethasone 62 treatment naive genotype 62 Infusion reactions 62 refractory gout 62 HCV RESPOND 2 62 Epothilone D 62 markets COLAZAL 62 constipation OIC 62 PD LID 62 Vitrasert R 62 pralatrexate injection folate analogue 62 treat atrial flutter 62 Acute Exacerbations 62 Emtriva Viread 62 Aryplase 62 neutropenia dehydration dyspnea 62 oxycodone CR 62 metastatic hormone refractory 62 memantine HCl 62 novel orally inhaled 62 XL# anticancer compounds 62 dosing cohort 62 asthma rheumatoid arthritis 62 palonosetron hydrochloride Injection Dacogen 62 MKC# MT 62 6R BH4 62 allogeneic HSCT 62 histologic subtype 62 treat chronic rhinosinusitis 62 receiving concomitant corticosteroids 62 confirmatory Phase IIIb 62 HIV HCV coinfected 62 genitourinary GU 62 hematopoietic cancers 62 idiopathic PD 62 Severe hypersensitivity reactions 62 maximal doses 62 steroid refractory ulcerative 62 YOUR LOCAL ANIMAL SHELTER 62 bupropion SR 62 oral antidiabetic medication 62 systemic lupus erythematosus rheumatoid 62 virologically suppressed 62 AN# topical anti 62 delta opioid receptor 62 personalized cellular immunotherapy 62 mg q#h 62 Refractory Hodgkin Lymphoma 62 echocardiographic parameters 62 headache abdominal pain 62 prokinetic agent 62 syndrome gastroesophageal reflux 62 mcg albinterferon alfa 2b 62 Ophena TM 62 Tarceva TM 62 smoldering multiple myeloma 62 virus HCV protease inhibitor 62 Dr. Assa Amit 62 TNFerade ™ 62 CCR5 mAb 62 Initiates Enrollment 62 platelet aggregation inhibitors 62 venlafaxine XR 62 High Dose quadruples 62 Sapacitabine 62 ritonavir boosted atazanavir 62 containing abacavir 62 VBLOC vagal blocking 62 Relapsing remitting MS 62 Meets Primary Endpoint 62 gastrointestinal GI motility disorders 62 phase Ib 62 LHRH receptor positive 62 related CMV Retinitis 62 salmeterol fluticasone 62 MIRAPEX 62 unresectable recurrent 62 Colon polyps 62 assessing T DM1 62 ZACTIMA 62 receptor tyrosine kinase inhibitor 62 diarrhea headache nausea 62 CTA# Injection 62 Staccato prochlorperazine 62 estrogen receptor beta agonist 62 solanezumab 62 OvaRex ® MAb 62 unstable angina pectoris 62 Zolpimist ™ 62 hepatorenal syndrome 62 refractory CLL 62 aspirin clopidogrel 62 cause mesothelioma asbestosis 62 candidate SILENOR TM 62 anaphylactic reactions bronchospasm 62 ARCOXIA 62 develop HBV reactivation 62 used DNA alkylating 62 Letairis ambrisentan 62 ACAPODENE TM 62 CHD CVD 62 neovascular form 62 Prozac Paxil Zoloft Celexa 62 MIRAPEX ER 62 diabetic kidney 62 indolent follicular non 62 Erythropoietic therapies may 62 Lexapro Effexor Serzone 62 refractory metastatic colorectal cancer 62 refractory AML 62 TELINTRA R 62 budesonide pMDI 62 HBeAg negative patients 62 rALLy 62 recurrent malignant glioma 62 glycoprotein IIb IIIa inhibitor 62 patients undergoing CABG 62 bacillus Calmette Guerin BCG 62 undergone radical prostatectomy 62 Brinavess 62 haematologic 62 ZOLINZA 62 Pegloticase 62 Tectin TM 62 metastatic carcinoid 62 Proellex TM 62 HCV SPRINT 62 receiving chemoradiation therapy 62 psychiatric disorders ATI 62 T1c 62 Urocortin 2 62 metastatic bladder 62 developing ACAPODENE 62 inflammation metabolic disorders 62 severe exacerbations 62 Serious adverse reactions 62 Perforomist ™ Inhalation Solution 62 candidates Azedra TM 62 biliary tract cancer 62 PARGLUVA 61 Entereg R 61 K ras mutations 61 induced tumor regression 61 double blinded placebo 61 systemic corticosteroid 61 ancrod 61 NS5B polymerase 61 AML MDS 61 motesanib 61 Luveris R Ovidrel R 61 Omacetaxine 61 Angiotensin receptor blockers 61 Combination REOLYSIN R 61 unfractionated heparin UFH 61 underwent prostate biopsy 61 controlled dose escalation 61 novel emulsion formulation 61 known dihydropyrimidine dehydrogenase 61 tramiprosate Alzhemed TM 61 metaglidasen 61 induced macular edema 61 SinuNase TM 61 retinal thrombosis hemorrhages 61 abacavir lamivudine 61 neutropenia thrombocytopenia 61 diabetic peripheral neuropathic DPN 61 pentadentate logo R 61 Second Pivotal Phase 61 Initiate Phase 61 active comparator 61 Navelbine ® 61 inhaled tobramycin 61 common neurovascular complication 61 Aflibercept 61 SPRYCEL ® 61 severe renal impairment 61 angina myocardial infarction 61 acute peptic ulcer 61 KRAS mutations occur 61 relapsed multiple myeloma 61 #mg/day [001] 61 worsening thrombocytopenia 61 valsartan amlodipine 61 QNEXA ® 61 concomitant cardiac 61 Aeolus Pharmaceuticals Announces 61 pan histone deacetylase 61 TM pralatrexate injection 61 moderate renal impairment 61 lung esophageal 61 uremic pruritus 61 #-THOUSAND DOLLAR 61 hypertension hypercholesterolemia 61 CAPACITY trials 61 iloprost synthetic compound 61 CALGB # [002] 61 intravenous belinostat 61 accompanying electrolyte abnormalities 61 atypical Hemolytic Uremic Syndrome 61 relapsed leukemia 61 neuro inflammatory disorders 61 Alzhemed TM 61 microgram kg 61 metastatic HRPC 61 Suppository Hydrocortisone Acetate Rectal 61 trastuzumab Herceptin ® 61 potent triglyceride lowering 61 zolmitriptan 61 underwent liver transplantation 61 recurrent glioblastoma 61 COLAZAL ® 61 EQUIP OB 61 modified glutathione analog 61 heavily pretreated 61 BCG refractory carcinoma 61 Evoltra ® 61 Non inferiority 61 PRIMO CABG 61 XL# SAR# 61 BYSTOLIC 61 induce remission 61 smoldering myeloma 61 Sodium oxybate 61 zileuton injection 61 HBeAg negative 61 bone marrow malignancy 61 Gel repository corticotropin injection 61 taxane resistant 61 involuntary dyskinetic movements 61 underwent CABG 61 bepotastine besilate nasal spray 61 TNF Tumor Necrosis Factor 61 quetiapine Seroquel 61 Azmacort R 61 interferon beta therapy 61 evaluate ZFP Therapeutic 61 Gemzar gemcitabine 61 pegylated interferon alfa 2a 61 hyperlipemia 61 evaluating REVLIMID 61 Annamycin 61 BoNTA 61 refractory cutaneous T 61 ADL# novel 61 lipid lowering agents 61 glipizide plus 61 rALLy clinical trial 61 number NCT# ClinicalTrials.gov 61 bevirimat Study 61 tranquilizers diazepam 61 banned Darvon Darvocet 61 osteolytic bone disease 61 anticoagulant warfarin 61 LAB CGRP 61 mcg kg REBETOL 61 GRN# 61 CDAD Clostridium difficile 61 rheumatoid arthritis osteoarthritis ankylosing 61 ß blockers 61 infarction NSTEMI 61 heFH 61 immunomodulatory therapy 61 vaccine GMK 61 thromboembolic complications 61 non nucleoside inhibitor 61 Carotid Revascularization Endarterectomy vs. 61 includes AstraZeneca Accolate 61 Evidence Therapeutic 61 nonhematologic adverse reactions 61 carcinoma mCRC 61 Pivotal Phase III 61 NSABP C 61 Prodarsan R 61 BRIM2 61 ergot derivatives 61 metastatic androgen independent 61 nicardipine 61 Sudhir Agrawal D.Phil 61 prior chemotherapy regimens 61 Pfizer Camptosar 61 Dupuytren Disease 61 VELCADE melphalan 61 INTEGRILIN R 61 unstable angina UA 61 NEBIDO VANTAS SUPPRELIN LA 61 antiplatelet medications 61 PRIMO CABG2 61 Initiates Phase II 61 hypercholesterolemic patients 61 Avandia Actos 61 Lung transplantation 61 GEM OS2 61 Auxilium anticipates 61 GSK# [002] 61 urinary N telopeptide 61 selective phosphodiesterase 61 diarrhea predominant irritable 61 GATTEX ™ 61 prolonged QT interval 61 Phenoptin 61 TBC# 61 CYP#A# CYP#D# 61 alvespimycin 61 intravenous cyclophosphamide 61 plus prednisone 61 Charles Dullin School 61 ATACAND 61 CYT# vascular disrupting 61 HPV vaccine GlaxoSmithKline Cervarix 61 Dual Opioid 61 #mg dosing group 61 cognitive impairment associated 61 developing Bicifadine serotonin 61 refractory metastatic 61 2 methoxyestradiol 61 TOCOSOL Camptothecin 61 NOXAFIL Oral Suspension 61 infectious diseases autoimmune diseases 61 BEXXAR Therapeutic Regimen 61 systemic Phase 1b 61 im peramivir 61 vitamin B# folic acid 61 balloon hem minidresses 61 budesonide MMX Phase III 61 thetreatment 61 urocortin 2 61 Submits Response 61 allosteric modulator PAM 61 asymptomatic metastatic 61 aerosolized AAT 61 Namenda ® 61 Plaquenil 61 R ferumoxytol Injection 61 Rigel R# 61 leukemia multiple myeloma 61 Stage IIIB IV 61 unresectable malignant mesothelioma UMM 61 Veronate R 61 BENICAR HCT 61 membranous nephritis 61 PF # [002] 61 nonmelanoma 61 hormone refractory metastatic prostate 61 pediatric Crohn disease 61 via intradermal injections 61 Initiates Phase III 61 antibody MAb 61 ZACTIMA TM ZD# 61 orally administered inhibitor 61 Pemetrexed 61 radiation chemoradiation 61 thalidomide Thalomid 61 Achieves Primary Endpoint 61 equi analgesic doses 61 neurogenic orthostatic hypotension NOH 61 data management Clintrial 61 VIIBRYD 61 folinic acid 61 unresectable locally advanced 61 BUPHENYL 61 adjunctive placebo 61 NU# direct 61 management biostatistical analysis 61 oral methylnaltrexone 61 YONDELIS 61 CINQUIL 61 steroid refractory GvHD 61 teriflunomide 61 Phase III Pivotal 61 subcutaneous methylnaltrexone 61 hour bronchodilation 61 hyperplasia BPH 61 mg administered orally 61 ALN HPN 61 aldosterone antagonist 61 post herpetic neuralgia PHN 61 anticlotting drugs 61 clevidipine 60 multicenter placebo controlled 60 adalimumab Humira 60 xanthine oxidase inhibitor 60 oxymorphone ER 60 symptomatic BPH 60 mL/min/#.# m 2 60 Myelodysplastic Syndrome MDS 60 damage cirrhosis liver 60 chemosensitizer 60 refractory colorectal cancer 60 microbiologically evaluable 60 Intravitreal injections 60 landmark ATHENA 60 REMINYL ® 60 IMPACT DCM trial 60 irinotecan cisplatin 60 pegylated interferon alpha 60 ritonavir boosted 60 CG# oncolytic virus 60 interferon alpha IFN 60 RECORD1 60 thrombo embolic 60 Intravitreal 60 basal bolus regimen 60 Cojocaru correspondent 60 Obatoclax 60 Clot Busting 60 TEAEs 60 RLAI 60 acute porphyria 60 DG# compounds targeting 60 rheumatoid arthritis inflammatory bowel 60 Abrupt discontinuation 60 Ception Therapeutics Inc. 60 TNF blocker therapy 60 RRMS patients 60 J Antimicrob Chemother 60 endothelin antagonists 60 REM Scissor Sisters 60 IMiDs ® compound 60 methylnaltrexone bromide 60 LibiGel Phase III 60 evaluating Xcytrin 60 headache tiredness dizziness 60 leukemia APL 60 commercialize deforolimus 60 torsade de pointes 60 systemic invasive fungal 60 Chronic lymphocytic leukemia 60 GATTEX ® 60 #mg BID [001] 60 AEG# 60 5 FU leucovorin 60 Fibrillex TM 60 COLAZAL R 60 bone spurs bulging 60 Warfarin Coumadin 60 Darusentan 60 chronic progressive neurodegenerative 60 relapsed myeloma 60 Novartis Trileptal 60 AIR CF1 60 Aggrastat ® tirofiban hydrochloride 60 rosuvastatin Crestor 60 receiving PEGINTRON 60 estradiol gel indicated 60 treat secondary hyperparathyroidism 60 locoregional recurrence 60 hyaluronidase enzyme 60 Hypoactive Sexual Desire Disorder 60 proprietary intravenous formulation 60 phase IIb clinical 60 maximal tolerated 60 quetiapine risperidone 60 Tesmilifene 60 recurrent NSCLC 60 peripheral arterial occlusive disease 60 EDEMA3 60 Vertex hepatitis C 60 systemic hypotension 60 mild hepatic impairment 60 selective angiogenic kinase inhibitor 60 Pegasys plus Copegus 60 severe malignant osteopetrosis 60 Begins Dosing 60 ABSORB clinical 60 CIMZIA ™ 60 Triapine R 60 NATRECOR ® 60 signal detection CTSD 60 cyclophosphamide methotrexate 60 severe mitral regurgitation 60 Inc. www.micromet inc.com 60 NUCYNTA ™ 60 Phase IIb REGENESIS 60 undergoing peritoneal dialysis 60 GOUT 60 painful diabetic neuropathy 60 Breast conserving 60 Femara letrozole 60 macular edema secondary 60 recurrent genital herpes 60 Acute myelogenous leukemia 60 Elestrin ® 60 minimally symptomatic 60 sitaxsentan 60 non CF bronchiectasis 60 PSMA ADC 60 FOLFOX6 60 Panzem R NCD 60 Archexin 60 oral ridaforolimus 60 Initiates Clinical Trial 60 Active Ulcerative Colitis 60 Intermezzo ® zolpidem tartrate 60 successfully commercialize Iluvien 60 Velcade bortezomib 60 opioid bowel dysfunction 60 receiving immunosuppressive therapy 60 beta 1a 60 rectal tenesmus 60 Gamunex C 60 null responder HCV 60 got Abbott MitraClip 60 http:/www.vivus.com 60 Canvaxin TM 60 prospective randomized multicenter 60 NMIBC 60 collagen vascular 60 subcutaneous PRO 60 PROSTVAC VF 60 5 fluorouracil leucovorin 60 TRAIL receptor antibody mapatumumab 60 blind multicenter 60 postoperative chemotherapy 60 plus gemcitabine 60 sertraline Zoloft 60 3 registrational trial 60 singer Jazzie B. 60 sarcoma melanoma 60 Gold NZDUSD USDSGD 60 failure NYHA 60 ADAGEN 60 IMiDs R 60 SinuNase ™ 60 ACTOplus met XR 60 plus methotrexate 60 lomitapide 60 Stage IIB 60 Pruvel ™ prulifloxacin 60 pamidronate 60 intravenous bolus 60 commercializing oxidized glutathione 60 TRANSDUR ® 60 4mg/kg 60 maximally tolerated 60 ViaDerm hPTH #-# 60 interferon ribavirin 60 Pruvel TM 60 papillary renal cell carcinoma 60 Hormone pills 60 pancreas esophagus 60 Chronic lymphocytic leukemia CLL 60 Sirtex SIR Spheres microspheres 60 comparator arm 60 DIRECT Trial 60 Panzem R 60 acute humoral rejection 60 Phase #b/#a clinical 60 Empatic TM 60 mixed hyperlipidemia 60 BCR ABL inhibitor 60 adenosine injection 60 MGd 60 non alcoholic steatohepatitis 60 6 sulfatase 60 D aspartate NMDA receptor 60 epirubicin cyclophosphamide 60 rufinamide 60 Stab stab 60 3TC lamivudine 60 EDEMA3 trial 60 AKT inhibitor 60 Platinol ® cisplatin 60 resistant hormone refractory 60 refractory multiple myeloma 60 barbiturates benzodiazepines 60 antiangiogenesis therapies 60 HMG CoA reductase inhibitors 60 Vascular Disrupting Agent 60 Pivotal Phase 60 oral ghrelin agonist 60 nucleoside naive 60 PI3K/Akt pathway inhibitor 60 dose intramuscular 60 novel chimeric natriuretic 60 PREZISTA ritonavir 60 GetGoal Phase III 60 previously untreated follicular 60 somnolence dizziness 60 GW# [003] 60 didanosine associated 60 midstage trials 60 childbearing age mirrors 60 acute mania 60 interferon alfa 2b 60 Depressed bipolar 60 Adenoscan R 60 isolated hypertriglyceridemia 60 PresbyLens ® 60 APTIVUS r 60 generation purine nucleoside 60 related DHFR inhibitors 60 refractory myeloma 60 DEB# 60 beclomethasone dipropionate 60 calcineurin inhibitor 60 reversing heparin 60 virus HCV infection 60 eosinophilic asthma 60 ASG 5ME dacetuzumab SGN 60 coronary stent merged 60 plus dexamethasone 60 Known hypersensitivity 60 unresectable Stage III 60 tamoxifen Nolvadex ® 60 biologic antibody 60 bladder ovarian 60 mg RDEA# 60 Matrix Phase 2b 60 hypertension osteoarthritis 60 non thiazolidinedione TZD 60 injectable investigational 60 dermatologic reactions 60 argatroban 60 hepatitis C genotype 60 underwent surgical resection 60 stroke hypertension palpitations 60 dyslipidemia abnormal 60 completely resected 60 Qnexa TM 60 arterial thromboembolic 60 #:#-#,# CrossRef Medline [001] 60 adult chronic ITP 60 Omnitarg 60 refractory indolent non 60 linaclotide treated 60 Degarelix 60 non squamous histology 60 interferon alfa 2a 60 nonsmall cell lung cancer 60 ramipril Altace 60 Bezielle 60 docetaxel Taxotere ® 60 pediatric malignancies 60 chronic thromboembolic pulmonary 60 NYHA Class III 60 Risperdal Zyprexa 60 oral levofloxacin 60 CCR9 antagonist 60 influenza BCX# purine nucleoside 60 neurologic progression 60 paclitaxel cisplatin 60 antiplatelets 60 drug figitumumab 60 OSI Tarceva 60 elotuzumab 60 #mg QD [002] 60 cutaneous T 60 cerebrovascular events 60 d l leucovorin 60 monoclonal antibody IgG1 Mab 60 VICTOR E1 60 systemic autoimmune 60 lamotrigine Lamictal 60 recurrent DVT 60 later Ettore Campogalliani 60 Braylon Edwards bushy beard 60 primidone 60 doxepin hydrochloride 60 leukemia AML 60 nonmetastatic 60 oral picoplatin 60 systemic RNAi therapeutic 60 genotypic resistance 60 Forodesine HCl 60 risedronate sodium tablets 60 Fludara ® 60 Arterial stiffness 60 venlafaxine ER 60 constipation predominant irritable bowel 60 Personalized Immunotherapy 60 atrial fibrillation budiodarone ATI 59 symptomatic hyponatremia 59 MONDAYS Bingo 59 ASH Abstract # 59 treating sarcoma testicular 59 Fireworks resounded 59 gastrointestinal mucositis